Coldstream Capital Management Inc. Sells 14,632 Shares of The Clorox Company $CLX

Coldstream Capital Management Inc. decreased its holdings in The Clorox Company (NYSE:CLX) by 83.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,881 shares of the company’s stock after selling 14,632 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Clorox were worth $290,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Center for Financial Planning Inc. bought a new position in Clorox in the 3rd quarter valued at $25,000. Vermillion & White Wealth Management Group LLC bought a new position in Clorox in the 3rd quarter valued at $25,000. Darwin Wealth Management LLC bought a new position in Clorox in the 2nd quarter valued at $29,000. Vision Financial Markets LLC raised its position in Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares during the last quarter. Finally, Ameriflex Group Inc. raised its position in Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 6.5%

Shares of Clorox stock opened at $89.98 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03. The business has a fifty day simple moving average of $98.46 and a 200 day simple moving average of $105.81. The stock has a market cap of $10.88 billion, a PE ratio of 14.61, a price-to-earnings-growth ratio of 0.47 and a beta of 0.59.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the previous year, the firm earned $1.45 earnings per share. The firm’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Insider Activity at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.63% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CLX has been the subject of several research analyst reports. The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research report on Friday, May 1st. Jefferies Financial Group cut their price objective on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Barclays cut their price objective on Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Finally, Rothschild & Co Redburn set a $117.00 price objective on Clorox in a research report on Friday, February 13th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $103.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.